-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Upgrades Evolent Health to Buy, Maintains Price Target to $6

Benzinga·11/20/2026 13:25:35
Listen to the news
Truist Securities analyst Jailendra Singh upgrades Evolent Health (NYSE:EVH) from Hold to Buy and maintains the price target from $6 to $6.